Virulence and antimicrobial resistance profiles among Escherichia coli strains isolated from human and animal wastewater

Research in Microbiology

Volumn 159, Issue 4, 2008, Pages 288-293

  Sabaté, Montserrat ^a   Prats, Guillem ^a   Moreno, Eva ^a   Ballesté, Elisenda ^b   Blanch, Anicet R ^b   Andreu, Antonia ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Antimicrobial resistance; Escherichia coli; Pathogenicity islands; Phylogenetic group

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAMASE; QUINOLONE; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; CONTROLLED STUDY; ESCHERICHIA COLI; NONHUMAN; PHYLOGENY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; WASTE WATER;

ANIMALS; ANTI-BACTERIAL AGENTS; CATTLE; CHICKENS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; GENOMIC ISLANDS; HUMANS; PHYLOGENY; SEWAGE; SWINE; VIRULENCE;

ANIMALIA; ESCHERICHIA COLI;

EID: 44649152997     PISSN: 09232508     EISSN: 17697123     Source Type: Journal    
DOI: 10.1016/j.resmic.2008.02.001     Document Type: Article

References (41)

1. Andreu A., and Planells I. Cooperative Spanish group for the study of antimicrobial susceptibility of urinary pathogens. Etiology of community-acquired lower urinary infections and antimicrobial resistance of Escherichia coli: a national surveillance study. Med. Clin. (Barc.) 130 (2008) in press
2. Blanch A.R., Belanche-Munoz L., Bonjoch X., Ebdon J., Gantzer C., Lucena F., et al. Integrated analysis of established and novel microbial and chemical methods for microbial source tracking. Appl. Environ. Microbiol. 72 (2006) 5915-5926
3. Brinas L., Moreno M.A., Teshager T., Saenz Y., Porrero M.C., Dominguez L., et al. Monitoring and characterization of extended-spectrum beta-lactamases in Escherichia coli strains from healthy and sick animals in Spain in 2003. Antimicrob. Agents Chemother. 49 (2005) 1262-1264
4. Clermont O., Bonacorsi S., and Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66 (2000) 4555-4558
5. Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. M100-S15, Fifteenth informational supplement (2005), Clinical Laboratory Standards Institute, Wayne, PA
6. Dobrindt U., Blum-Oehler G., Nagy G., Schneider G., Johann A., Gottschalk G., et al. Genetic structure and distribution of four pathogenicity islands (PAI I(536) to PAI IV(536)) of uropathogenic Escherichia coli strain 536. Infect. Immun. 70 (2002) 6365-6372
7. Grabow W.O.K. In: McFeters G.A. (Ed). Microbiology of drinking water treatment: reclaimed wastewater (1990), Springer-Verlag, New York 185-203
8. Guyer D.M., Kao J.S., and Mobley H.L. Genomic analysis of a pathogenicity island in uropathogenic Escherichia coli CFT073: distribution of homologous sequences among isolates from patients with pyelonephritis, cystitis, and Catheter-associated bacteriuria and from fecal samples. Infect. Immun. 66 (1998) 4411-4417
9. Hacker J., Blum-Oehler G., Muhldorfer I., and Tschape H. Pathogenicity islands of virulent bacteria: structure, function and impact on microbial evolution. Mol. Microbiol. 23 (1997) 1089-1097
10. Houdouin V., Bonacorsi S., Bidet P., Bingen-Bidois M., Barraud D., and Bingen E. Phylogenetic background and carriage of pathogenicity island-like domains in relation to antibiotic resistance profiles among Escherichia coli urosepsis isolates. J. Antimicrob. Chemother. 58 4 (2006) 748-751
11. International Standardisation Organisation. ISO 5667-1. Water quality. Sampling. Part 3: Guidance on the design of sampling programmes (1980), International Standardisation Organisation, Geneva (Switzerland)
12. International Standardisation OrganisationISO 5667-2. Water quality. Sampling. Part 2: Guidance on sampling techniques (1982), International Standardisation Organisation, Geneva (Switzerland)
13. International Standardisation OrganisationISO 6887. Microbiology - general guidance for the preparation of dilutions for microbiological examination (1983), International Standardisation Organisation, Geneva (Switzerland)
14. International Standardisation OrganisationISO 5667-3. Water quality. Sampling. Part 3: Guidance on the preservation and handling of samples (1985), International Standardisation Organisation, Geneva (Switzerland)
15. International Standardisation OrganisationISO 31-0. Quantities and units. Part 0: General principles (1992), International Standardisation Organisation, Geneva (Switzerland)
16. Johnson J.R. Virulence factors in Escherichia coli urinary tract infection. Clin. Microbiol. Rev. 4 (1991) 80-128
17. Johnson J.R. Antimicrobial drug-resistant Escherichia coli from humans and poultry products, Minnesota and Wisconsin, 2002-2004. Emerg. Infect. Dis. 13 (2007) 838-846
18. Johnson J.R., Johnston B., Kuskowski M.A., Colodner R., and Raz R. Spontaneous conversion to quinolone and fluoroquinolone resistance among wild-type Escherichia coli isolates in relation to phylogenetic background and virulence genotype. Antimicrob. Agents Chemother. 49 (2005) 4739-4744
19. Johnson J.R., Kuskowski M.A., Gajewski A., Sahm D.F., and Karlowsky J.A. Virulence characteristics and phylogenetic background of multidrug-resistant and antimicrobial-susceptible clinical isolates of Escherichia coli from across the United States, 2000-2001. J. Infect. Dis. 190 (2004) 1739-1744
20. Johnson J.R., Kuskowski M.A., Menard M., Gajewski A., Xercavins M., and Garau J. Similarity between human and chicken Escherichia coli isolates in relation to ciprofloxacin resistance status. J. Infect. Dis. 194 (2006) 71-78
21. Johnson J.R., Kuskowski M.A., Owens K., Gajewski A., and Winokur P.L. Phylogenetic origin and virulence genotype in relation to resistance to fluoroquinolones and/or extended-spectrum cephalosporins and cephamycins among Escherichia coli isolates from animals and humans. J. Infect. Dis. 188 (2003) 759-768
22. Johnson J.R., Murray A.C., Gajewski A., Sullivan M., Snippes P., Kuskowski M.A., et al. Isolation and molecular characterization of nalidixic acid-resistant extraintestinal pathogenic Escherichia coli from retail chicken products. Antimicrob. Agents Chemother. 47 (2003) 2161-2168
23. Kuhn I., Iversen A., Burman L.G., Olsson-Liljequist B., Franklin A., Finn M., et al. Comparison of enterococcal populations in animals, humans, and the environment-a European study. Int. J. Food Microbiol. 88 (2003) 133-145
24. Martinez-Martinez L., Fernandez F., and Perea E.J. Relationship between haemolysis production and resistance to fluoroquinolones among clinical isolates of Escherichia coli. J. Antimicrob. Chemother. 43 (1999) 277-279
25. Maynard C., Bekal S., Sanschagrin F., Levesque R.C., Brousseau R., Masson L., et al. Heterogeneity among virulence and antimicrobial resistance gene profiles of extraintestinal Escherichia coli isolates of animal and human origin. J. Clin. Microbiol. 42 (2004) 5444-5452
26. Mesa R.J., Blanc V., Blanch A.R., Cortes P., Gonzalez J.J., Lavilla S., et al. Extended-spectrum beta-lactamase-producing Enterobacteriaceae in different environments (humans, food, animal farms and sewage). J. Antimicrob. Chemother. 58 (2006) 211-215
27. Moreno E., Planells I., Prats G., Planes A.M., Moreno G., and Andreu A. Comparative study of Escherichia coli virulence determinants in strains causing urinary tract bacteremia versus strains causing pyelonephritis and other sources of bacteremia. Diagn. Microbiol. Infect. Dis. 53 (2005) 93-99
28. Moreno E., Prats G., Planells I., Planes A.M., Perez T., and Andreu A. Characterization of Escherichia coli isolates derived from phylogenetic groups A and B1 causing extraintestinal infection. Enferm. Infect. Microbiol. Clin. 24 (2006) 483-489
29. Moreno E., Prats G., Sabate M., Perez T., Johnson J.R., and Andreu A. Quinolone, fluoroquinolone and trimethoprim/sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropathogenic Escherichia coli. J. Antimicrob. Chemother. 57 (2006) 204-211
30. Oteo J., Lazaro E., de Abajo F.J., Baquero F., and Campos J. Antimicrobial-resistant invasive Escherichia coli. Spain. Emerg. Infect. Dis. 11 (2005) 546-553
31. Picard B., Garcia J.S., Gouriou S., Duriez P., Brahimi N., Bingen E., et al. The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect. Immun. 67 (1999) 546-553
32. Russo T.A., and Johnson J.R. Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC. J. Infect. Dis. 181 (2000) 1753-1754
33. Sabate M., Moreno E., Perez T., Andreu A., and Prats G. Pathogenicity island markers in commensal and uropathogenic Escherichia coli isolates. Clin. Microbiol. Infect. 12 (2006) 880-886
34. Schmidt H., and Hensel M. Pathogenicity islands in bacterial pathogenesis. Clin. Microbiol. Rev. 17 (2004) 14-56
35. Schneider G., Dobrindt U., Bruggemann H., Nagy G., Janke B., Blum-Oehler G., et al. The pathogenicity island-associated K15 capsule determinant exhibits a novel genetic structure and correlates with virulence in uropathogenic Escherichia coli strain 536. Infect. Immun. 72 (2004) 5993-6001
36. Soto S.M., Jimenez de Anta M.T., and Vila J. Quinolones induce partial or total loss of pathogenicity islands in uropathogenic Escherichia coli by SOS-dependent or -independent pathways, respectively. Antimicrob. Agents Chemother 50 (2006) 649-653
37. Swenson D.L., Bukanov N.O., Berg D.E., and Welch R.A. Two pathogenicity islands in uropathogenic Escherichia coli J96: cosmid cloning and sample sequencing. Infect. Immun. 64 (1996) 3736-3743
38. Versalovic J., Koeuth T., and Lupski J.R. Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Res. 19 (1991) 6823-6831
39. Vila J., Simon K., Ruiz J., Horcajada J.P., Velasco M., Barranco M., et al. Are quinolone-resistant uropathogenic Escherichia coli less virulent?. J. Infect. Dis. 186 (2002) 1039-1042
40. Vilanova X., Manero A., Cerda-Cuellar M., and Blanch A.R. The composition and persistence of faecal coliforms and enterococcal populations in sewage treatment plants. J. Appl. Microbiol. 96 (2004) 279-288
41. Young H.K. Antimicrobial resistance spread in aquatic environments. J. Antimicrob. Chemother. 31 (1993) 627-635